Search results for "THROMBOSIS"

showing 10 items of 630 documents

Comparación de las frecuencias de los alelos factor V Leiden (G1691A) y protrombina-G20210A entre pacientes con trombosis venosa profunda y población…

2006

Background: Factor V leiden and the -G20210A variant of prothrombin gene are associated to a higher risk of deep venous thrombosis. Aim: To assess the frequency of factor V Leiden (G1691A) and prothrombin -G20210A alleles in patients with deep venous thrombosis (DVT) and in the general population from Spain. Material and methods: Factor V Leiden (g1691a) and prothrombin-g20210a alleles were genotyped in 493 individuals from the Spanish general populations and in 131 patients with DVT. The presence of DVT was confirmed by phlebography. Allelic frequencies and the DVT risk associated with these variants were estimated. Results: Allelic frequencies for the factor V Leiden (G1691A) allele were …

medicine.medical_specialtyPopulationGastroenterologyInternal medicinehemic and lymphatic diseasesGenotypeG20210AVenous thrombosismedicineFactor V Leidencardiovascular diseasesAlleleeducationAlleleseducation.field_of_studyFactor V Leidenbusiness.industryGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalSurgeryVenous thrombosisProthrombin geneProthrombin G20210Abusiness
researchProduct

Sequentielle transarterielle Chemoembolisation (TACE) des hepatozellulären Karzinoms (HCC) - Erfahrungsbericht eines einzelnen Zentrums über 5 Jahre

2007

PURPOSE: To analyze the course of disease of patients treated with sequential TACE and to evaluate the dependent and independent prognostic factors for patient survival using the Cox Proportional Hazard Model. MATERIALS AND METHODS: 94 patients palliatively treated with TACE. Patients were selected if they had been treated at least 3 times. The TACE procedure was carried out at 8-week intervals using a suspension consisting of a fixed dosage of Mitomycin C (10 mg) and 10 ml Lipiodol. Follow-up investigations included contrast-enhanced multislice CT before and after TACE and assessment of the laboratory test results (i. e., blood count, liver enzymes, and coagulation). RESULTS: In 66.7 % of …

medicine.medical_specialtyProportional hazards modelbusiness.industrymedicine.diseaseSingle CenterGastroenterologyPortal vein thrombosisTumor progressionInternal medicineHepatocellular carcinomaAscitesmedicineLipiodolRadiology Nuclear Medicine and imagingRadiologyLiver functionmedicine.symptombusinessmedicine.drugRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Utility of post mortem MRI in definition of thrombus in aneurismatic coronary arteries due to incomplete Kawasaki Disease in infants

2016

Abstract Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown etiology that primarily affects the coronary artery (CA) and presents in childhood. The characteristic coronary arterial lesion is an aneurysm, which may lead to thrombosis, dilatation, stenosis, and occlusion. Such an aneurysm is typically calcified and generally develops five or more years after the onset of acute KD. It becomes more noticeable after ten years. KD is sometimes difficult to diagnose because of the limited clinical features, especially in infants younger than 6 months old, where the clinical presentations often do not fulfill the diagnostic criteria for KD. We report a case of Incomplete Kawasaki…

medicine.medical_specialtyRadiology Nuclear Medicine and Imaging2734Aneurismatic coronary arterieAutopsy030204 cardiovascular system & hematology030218 nuclear medicine & medical imagingPathology and Forensic MedicineForensic pathology03 medical and health sciences0302 clinical medicineAneurysmIncomplete Kawasaki diseaseInternal medicinemedicinePost-mortem MRIThrombusbusiness.industrymedicine.diseaseThrombosisCoronary arteriesStenosismedicine.anatomical_structureSudden infant deathThrombosiCardiologyKawasaki diseasebusinessVasculitis
researchProduct

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor A Systematic Review

2010

Background We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis Annualized recurr…

medicine.medical_specialtyRate ratioRisk Assessmentlaw.inventionRandomized controlled triallawRecurrenceRisk FactorsInternal medicineEpidemiologyInternal MedicinemedicineHumansRisk factorProspective cohort studyFirst episodebusiness.industryIncidence (epidemiology)IncidenceVenous Thromboembolismvenous thrombosis recurrent eventmedicine.diseasePrognosisSurgeryVenous thrombosisbusiness
researchProduct

Cardiac arrest in special circumstances

2021

Purpose of review European Resuscitation Council Guidelines for Cardiopulmonary Resuscitation prioritize treatments like chest compression and defibrillation, known to be highly effective for cardiac arrest from cardiac origin. This review highlights the need to modify this approach in special circumstances. Recent findings Potentially reversible causes of cardiac arrest are clustered into four Hs and four Ts (Hypoxia, Hypovolaemia, Hyperkalaemia/other electrolyte disorders, Hypothermia, Thrombosis, Tamponade, Tension pneumothorax, Toxic agents). Point-of-care ultrasound has its role in identification of the cause and targeting treatment. Time-critical interventions may even prevent cardiac…

medicine.medical_specialtyResuscitationDefibrillationbusiness.industrymedicine.medical_treatmentWater-Electrolyte ImbalanceHypothermiaHypothermiaReturn of spontaneous circulationCritical Care and Intensive Care Medicinemedicine.diseaseThrombosisCardiopulmonary ResuscitationHeart ArrestPulmonary embolismPregnancymedicineHumansFemaleTamponadeCardiopulmonary resuscitationmedicine.symptomIntensive care medicinebusinessOut-of-Hospital Cardiac ArrestCurrent Opinion in Critical Care
researchProduct

European Resuscitation Council Guidelines for Resuscitation 2015

2015

Summary of changes since 2010 Guidelines The main changes in the ERC Guidelines 2015 in comparison with the Guidelines 20101are summarised below:Special causes•Survival after an asphyxia-induced cardiac arrest is rare and survivors often have severe neurological impairment. During CPR, early effective ventilation of the lungs with supplementary oxy-gen is essential.•A high degree of clinical suspicion and aggressive treatment can prevent cardiac arrest from electrolyte abnormalities. The new algorithm provides clinical guidance to emergency treatment of life-threatening hyperkalaemia.•Hypothermic patients without signs of cardiac instability(systolic blood pressure ≥90 mmHg, absence of vent…

medicine.medical_specialtyResuscitationbusiness.industrymedicine.medical_treatmentTraumatic cardiac arrestEmergency NursingHypoxia (medical)medicine.diseaseThrombosisTension pneumothoraxAdvanced life supportEmergency MedicineMedicineTamponadeCardiopulmonary resuscitationmedicine.symptomCardiac arrest Special Circumstances ResuscitationCardiology and Cardiovascular MedicinebusinessIntensive care medicineResuscitation
researchProduct

The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature.

2012

Inflammatory bowel diseases are associated with an increased risk of vascular complications. The most important are arterial and venous thromboembolisms, which are considered as specific extraintestinal manifestations of inflammatory bowel diseases. Among venous thromboembolism events, portal vein thrombosis has been described in inflammatory bowel diseases. We report three cases of portal vein thrombosis occurring in patients with active inflammatory bowel disease. In two of them, hepatic abscess was present. Furthermore, we performed a systematic review based on the clinical literature published on this topic.

medicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyClinical courseInflammatory Bowel DiseasesReview ArticleClinical literaturemedicine.diseaseGastroenterologyInflammatory bowel diseasePortal vein thrombosisIncreased riskInternal medicineportal thrombosis.inflammatory bowel diseaseMedicineIn patientlcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869businessVenous thromboembolism
researchProduct

C0307 Baseline characteristics and management of patients with splanchnic vein thrombosis: Results of an international registry

2012

medicine.medical_specialtySplanchnic vein thrombosisbusiness.industryInternal medicineBaseline characteristicsmedicineCardiologyHematologybusinessSurgeryThrombosis Research
researchProduct

C0322 Factors associated with therapeutic strategies in patients with splanchnic vein thrombosis: Results of an international registry

2012

medicine.medical_specialtySplanchnic vein thrombosisbusiness.industryInternal medicineCardiologymedicineIn patientHematologybusinessThrombosis Research
researchProduct

Evaluation of direct oral anticoagulants in superficial-vein thrombosis – Authors' reply

2017

medicine.medical_specialtySuperficial vein thrombosisbusiness.industryMEDLINEHematology030204 cardiovascular system & hematologymedicine.diseaseThrombosisSurgery03 medical and health sciencesVenous thrombosis0302 clinical medicinemedicine030212 general & internal medicinebusinessThe Lancet Haematology
researchProduct